BIOATLA INC
BCAB
BCAB was delisted on the 28th of August, 2026.
53 hedge funds and large institutions have $530M invested in BIOATLA INC in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.97% more ownership
Funds ownership: 0% → 0.97% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$106M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$76.6M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$65.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$59.5M |
| 5 |
Janus Henderson Group
London,
|
+$44M |
Top Sellers
BCAB Hedge Fund Activity: Q4 2020 in Review
53 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in BIOATLA INC (BCAB) for Q4 2020, worth a combined $530M.
Buyers outnumbered sellers: 53 funds opened new BCAB positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $106M.
- 53 institutional investors held BIOATLA INC (BCAB) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $530M of BIOATLA INC stock for Q4 2020.
- 53 funds opened new BIOATLA INC positions in Q4 2020 and 0 closed out, a net change of +53 holders.
- The largest BIOATLA INC buyer in Q4 2020 was Soleus Capital Management, an estimated $106M added.
Based on aggregated 13F filings for Q4 2020.